12.85
+0.78%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Kim Forest Enterprise Co
Its shares trade on Taiwan Stock Exchange under the ticker 6645.TW. It has been listed since 18 August 2017. In the fiscal year to 31 December 2025, it reported revenue of TWD 549.1m and a net loss of TWD 146.4m. At that date it held total assets of TWD 1.02bn and shareholders' equity of TWD 490.9m.
Kim Forest Enterprise Co., Ltd. engages in sale of instruments and reagents needed for new drug research and development. The company is headquartered in Taipei, New Taipei. The company went IPO on 2017-08-18. The firm operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 18 Aug 2017
- Website
- kimforest.com ↗
Leadership
Pay as last reported
- Mr. Pincong WuChairman of the Board, since 2004
- Xiuping ChenFinance Manager
- Mr. Wenming YangGeneral Manager
- Ms. Peishan WuDeputy General Manager-Biomedical Products Business Division
- Ms. Zhongchun WuDeputy General Manager
- Ms. Qianqi LinManager of Accounting
- Mr. Mingxi XiaoChief Research & Development Officer
- Ms. Wenlan XuCorporate Governance Officer
- Ms. Hui-O ChenDirector, since 2005
- Mr. Jianyu ChenDirector
- Ms. Yingru HongDirector
- Mr. Youzhong LinDirector, since 2020
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Kim Forest Enterprise Co Ltd offers advanced biotechnology equipment and reagents for drug development in Taipei, Taiwan.
- The company provides comprehensive laboratory services including PCR and DNA detection reagents for research.
- Biomedical Experiment Products segment delivers specialized equipment like microplate spectrophotometers and cell separation tools.
Weaknesses
- The company operates primarily in the Taipei region with limited international expansion.
- Kim Forest Enterprise Co Ltd has no presence in major global biotechnology markets like the US or Europe.
- Limited product diversification beyond laboratory equipment and genetic testing services.
Opportunities
- Growing demand for genomic sequencing services in the Health Care sector across Asia.
- Expansion into new markets such as Japan and South Korea for biotechnology products.
- Increased collaboration opportunities with pharmaceutical companies for drug development.
Threats
- Intense competition from established biotech firms in Taiwan's Health Care industry.
- Rising costs of research and development in the Information Technology sector.
- Regulatory challenges in the Biotechnology and Genetic Testing segment due to evolving standards.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.